EDRS
PPH icon

Edmond de Rothschild (Suisse)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$23K Buy
400
+200
+100% +$12K 0.01% 382
2016
Q2 		$12K Buy
+200
New +$11.7K ﹤0.01% 382

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
SCM
Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s PPH Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) increased its VanEck Pharmaceutical ETF (PPH) stake by 100% in Q3 2016, buying an estimated $12K and bringing the position to 400 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #382.

Edmond de Rothschild (Suisse) first reported a position in PPH in Q2 2016 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold PPH as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 400 shares of VanEck Pharmaceutical ETF worth $23K as of Q3 2016.
  • Edmond de Rothschild (Suisse) bought 200 VanEck Pharmaceutical ETF shares in Q3 2016, an estimated $12K.
  • VanEck Pharmaceutical ETF made up 0.01% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #382 holding.
  • Edmond de Rothschild (Suisse) first reported a position in VanEck Pharmaceutical ETF in Q2 2016 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.